INVX: financial statements from SEC — TradeAlmanac

INVX

Innovex International, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	978m	661m
Cost of revenue	675m	428m
Selling, general and administrative	129m	116m
Operating income	133m	49m
Interest expense	3m	2m
Pre-tax income	129m	143m
Income tax	45m	2m
Net income	83m	140m
Earnings per share	1.21	2.82
Earnings per share, diluted	1.20	2.77
Weighted average shares	69m	50m
Weighted average shares, diluted	69m	51m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Aug 31, 2024
Cash and equivalents	201m	203m	163m	69m	68m	73m	100m	—
Receivables	246m	238m

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	191m	93m
Depreciation and amortisation	61m	31m
Share-based compensation	14m	13m
Investing cash flow	−19m	78m
Dividends paid	0	75m
Financing cash flow	−45m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)